Clinical Trial

Patient Controlled Epidural Analgesia Versus Intravenous Patient Controlled Analgesia for Post-Operative Pain Control in Patients Undergoing Elective Liver Resection

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to learn whether patient-controlled epidural analgesia (PCEA) is a better method for managing pain after liver resection compared to patient-controlled analgesia (IV PCA). Currently, the standard pain control method for liver resection patients is IV PCA. There is not enough data on how epidural (PCEA) relieves pain and movement on a day to day basis after liver resection.
Protocol Amendment History 20 amendments
This ClinicalTrials.gov record has been amended 20 times since 2015-08-12; most recent amendment 2026-07-21.
Status change: Recruiting → Active, Not Recruiting 2020-07-20
Trial Details
NCT Number NCT02523443
Lead Sponsor Memorial Sloan Kettering Cancer Center
Conditions Liver Cancer, Pain Management
Enrollment 231 participants
Start Date 2015-08
Primary Completion 2026-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-07-22